EU Says AstraZeneca Must Meet Contractual, Moral Obligations

The EU insists that AstraZeneca must honor its vaccine delivery commitments amidst the pandemic, highlighting the human toll and the moral, societal, and contractual responsibilities of pharmaceutical companies. The EU rejects AstraZeneca's interpretation of their agreement and emphasizes the need for collaboration to resolve issues and rebuild trust.

What is the primary concern of the EU regarding AstraZeneca's vaccine delivery?

• The fulfillment of delivery commitments

• The quality of the vaccines

• The speed of delivery

• The cost of the vaccines

How does the EU view AstraZeneca's interpretation of the 'best effort' agreement?

• As a valid excuse for delays

• As a misunderstanding of the agreement

• As a reason to renegotiate terms

• As an acceptable business practice

What does the EU reject in terms of vaccine distribution logic?

• The idea of prioritizing based on population size

• The strategy of random allocation

• The concept of first come, first served

• The notion of distributing based on economic status

What is the EU's approach to resolving issues with AstraZeneca?

• Legal action

• Complete withdrawal from agreements

• Public protests

• Open engagement and collaboration

What does the EU expect from AstraZeneca to rebuild trust?

• Increased vaccine prices

• Complete transparency and adherence to obligations

• Reduction in vaccine production

• Exclusive contracts with the EU